HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alessandra Rubagotti Selected Research

Alessandra Rubagotti Research Topics

Disease

18Neoplasms (Cancer)
09/2022 - 08/2002
18Prostatic Neoplasms (Prostate Cancer)
07/2020 - 11/2002
15Breast Neoplasms (Breast Cancer)
09/2022 - 05/2003
3Mastodynia
11/2014 - 10/2005
2Circulating Neoplastic Cells
07/2020 - 09/2019
2Carcinogenesis
07/2015 - 03/2006
2Gynecomastia
11/2014 - 10/2005
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2008 - 12/2006
2Colorectal Neoplasms (Colorectal Cancer)
12/2006 - 08/2002
2Endometrial Neoplasms (Endometrial Cancer)
12/2006 - 08/2005
1Pain (Aches)
01/2018
1Hypokalemia
01/2018
1Testicular Neoplasms (Testicular Cancer)
10/2014
1Urogenital Neoplasms
10/2014
1Kidney Neoplasms (Kidney Cancer)
10/2014
1Carcinoma (Carcinomatosis)
09/2011
1Ovarian Epithelial Carcinoma
01/2005
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
06/2004
1Agranulocytosis (Granulocytopenia)
06/2004
1Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2004
1Breast Cyst
05/2003
1Cysts
05/2003
1Disease Progression
11/2002
1Aneuploidy (Aneuploid)
08/2002

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
09/2022 - 06/2003
6PeriostinIBA
07/2020 - 12/2012
6TamoxifenFDA LinkGeneric
04/2011 - 08/2005
5AndrogensIBA
01/2018 - 11/2002
5bicalutamide (Casodex)FDA LinkGeneric
03/2013 - 11/2002
3Androgen Receptors (Androgen Receptor)IBA
09/2019 - 09/2011
3Hormones (Hormone)IBA
09/2019 - 12/2006
3Nuclear Matrix-Associated ProteinsIBA
08/2012 - 06/2003
32,3-bis(3'-hydroxybenzyl)butyrolactone (enterolactone)IBA
04/2012 - 05/2003
3Aromatase InhibitorsIBA
03/2007 - 10/2005
3Anastrozole (Arimidex)FDA LinkGeneric
12/2006 - 08/2005
2Abiraterone AcetateIBA
09/2019 - 01/2018
2Docetaxel (Taxotere)FDA Link
09/2019 - 01/2018
2Prednisone (Sone)FDA LinkGeneric
01/2018 - 01/2008
2Androgen Antagonists (Antiandrogens)IBA
11/2014 - 10/2005
2Heterogeneous-Nuclear Ribonucleoprotein KIBA
05/2014 - 09/2011
2LignansIBA
04/2012 - 03/2006
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2010 - 06/2004
2Estrogen ReceptorsIBA
03/2007 - 08/2005
2Pharmaceutical PreparationsIBA
12/2006 - 10/2005
1Aspartic Acid (Aspartate)FDA Link
09/2022
1Mixed Function Oxygenases (Monooxygenases)IBA
09/2022
1Messenger RNA (mRNA)IBA
07/2020
1Extracellular Matrix ProteinsIBA
07/2020
1Biological ProductsIBA
01/2020
1Phenobarbital (Luminal)FDA Link
01/2020
1apalutamideIBA
09/2019
1enzalutamideIBA
09/2019
1Prostate-Specific Antigen (Semenogelase)IBA
01/2018
1Angiotensin IIIBA
11/2015
1Testosterone (Sustanon)FDA Link
11/2014
1Complement System Proteins (Complement)IBA
06/2013
1complement C3fIBA
06/2013
1Dihydrotestosterone (Androstanolone)IBA
03/2013
1afimoxifene (hydroxytamoxifen)IBA
09/2011
1imidazole mustard (BIC)IBA
09/2011
1Paclitaxel (Taxol)FDA LinkGeneric
01/2010
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2010
1Methotrexate (Mexate)FDA LinkGeneric
01/2010
1Fluorouracil (Carac)FDA LinkGeneric
01/2010
1Epirubicin (Ellence)FDA LinkGeneric
01/2010
1Gefitinib (Iressa)FDA Link
01/2008
1Biomarkers (Surrogate Marker)IBA
01/2008
1Tyrosine Kinase InhibitorsIBA
01/2008
1ErbB Receptors (EGF Receptor)IBA
01/2008
1Cyclin D1IBA
12/2006
1Cell Cycle ProteinsIBA
12/2006
1Lamin Type B (Lamin B)IBA
03/2006
1LaminsIBA
03/2006
1Estrogen Receptor Modulators (Antiestrogen)IBA
10/2005
1Oncogene Proteins (Oncogene Protein)IBA
01/2005
1Mitoxantrone (Novantrone)FDA LinkGeneric
06/2004
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2004
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2004
1fludarabineIBA
06/2004
1Anti-Bacterial Agents (Antibiotics)IBA
06/2004
1Epidermal Growth Factor (EGF)IBA
05/2003
1CationsIBA
05/2003
1Flutamide (Eulexin)FDA LinkGeneric
11/2002
1Goserelin (Zoladex)FDA Link
11/2002
1DAPIIBA
08/2002
1DNA (Deoxyribonucleic Acid)IBA
08/2002

Therapy/Procedure

6Therapeutics
01/2018 - 10/2005
5Castration
07/2020 - 11/2002
2Drug Therapy (Chemotherapy)
09/2015 - 04/2011
1Radiotherapy
09/2019
1Lasers (Laser)
11/2015
1Adjuvant Chemotherapy
09/2015
1Prostatectomy (Retropubic Prostatectomy)
06/2003